LU91147I2 - Pemetrexed et ses sels pharmaceutiquement acceptables. - Google Patents

Pemetrexed et ses sels pharmaceutiquement acceptables.

Info

Publication number: LU91147I2
Authority: LU; Luxembourg
Prior art keywords: pemetrexed; pharmaceutically acceptable; acceptable salts; salts; pharmaceutically
Prior art date: 1989-12-11

Application number

LU91147C

Other languages

English (en)

Original Assignee

Univ Princeton

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-12-11

Filing date

2005-03-14

Publication date

2005-05-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27503964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU91147(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-05-24 Priority claimed from US07/528,805 external-priority patent/US4996206A/en

2005-03-14 Application filed by Univ Princeton, Lilly Co Eli filed Critical Univ Princeton

2005-05-17 Publication of LU91147I2 publication Critical patent/LU91147I2/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Oncology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

LU91147C 1989-12-11 2005-03-14 Pemetrexed et ses sels pharmaceutiquement acceptables. LU91147I2 (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US44874289A	1989-12-11	1989-12-11
US47965590A	1990-02-08	1990-02-08
US07/528,805 US4996206A (en)	1989-12-11	1990-05-24	N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives
US07/528,155 US5028608A (en)	1989-12-11	1990-05-24	N-(6-Amino-(pyrrolo(2,3-d)pyrimidin-3-ylacyl) )-glutamic acid derivatives

Publications (1)

Publication Number	Publication Date
LU91147I2 true LU91147I2 (fr)	2005-05-17

Family

ID=27503964

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU91147C LU91147I2 (fr)	1989-12-11	2005-03-14	Pemetrexed et ses sels pharmaceutiquement acceptables.

Country Status (22)

Country	Link
EP (1)	EP0432677B1 (fr)
JP (1)	JP3016876B2 (fr)
CN (1)	CN1030608C (fr)
AR (1)	AR245129A1 (fr)
AT (1)	ATE135007T1 (fr)
AU (1)	AU640182B2 (fr)
CA (1)	CA2031890C (fr)
CY (1)	CY2076B1 (fr)
DE (2)	DE69025723T2 (fr)
DK (1)	DK0432677T3 (fr)
ES (1)	ES2084639T4 (fr)
GR (1)	GR3019784T3 (fr)
HK (1)	HK1000920A1 (fr)
HU (1)	HU218483B (fr)
IE (1)	IE904445A1 (fr)
IL (1)	IL96531A (fr)
LU (1)	LU91147I2 (fr)
NL (1)	NL300181I2 (fr)
NZ (1)	NZ236385A (fr)
PT (1)	PT96140B (fr)
RU (1)	RU2057131C9 (fr)
SG (1)	SG48098A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5254687A (en)	1991-12-04	1993-10-19	The Trustees Of Princeton University	Process for the preparation of pyrrolo[2,3-d]pyrimidines
US5235053A (en) *	1992-06-22	1993-08-10	Eli Lilly And Company	Process for the synthesis of 4-hydroxy-5-halopyrrold[2,3-d]pyrimidine intermediates
EP2316468A1 (fr)	2002-02-22	2011-05-04	Shire LLC	Système de distribution et méthodes de protection et d'administration de dextroamphetamine
CN100344615C (zh) *	2004-11-25	2007-10-24	重庆医药工业研究院有限责任公司	制备N－(吡咯并[2,3－d]嘧啶－5－基)酰基谷氨酸衍生物的方法及中间体
CN101146532B (zh)	2005-01-21	2012-05-09	阿斯泰克斯治疗有限公司	药物化合物
EP2270012A1 (fr)	2006-08-14	2011-01-05	Sicor, Inc.	Forme cristalline de diacide de pemetrexed et son procédé de préparation
US7994180B2 (en)	2006-08-14	2011-08-09	Sicor Inc.	Processes for preparing intermediates of pemetrexed
JP2008543975A (ja)	2006-08-14	2008-12-04	シコールインコーポレイティド	高度に純粋なペメトレキセド二酸およびその調製方法
KR101083230B1 (ko)	2006-08-14	2011-11-11	시코르, 인크.	페메트렉세드 이산의 동결 건조된 약학적 허용염의 제조 방법
EP2073807A1 (fr)	2006-10-12	2009-07-01	Astex Therapeutics Limited	Combinaisons pharmaceutiques
WO2008044041A1 (fr)	2006-10-12	2008-04-17	Astex Therapeutics Limited	Combinaisons pharmaceutiques
CN101417998B (zh)	2007-10-24	2012-10-24	重庆医药工业研究院有限责任公司	一种培美曲塞盐的纯化方法
ME02273B (me) *	2008-06-06	2016-02-20	Boehringer Ingelheim Int	Farmaceutska kombinacija
AU2015210337B2 (en) *	2008-06-06	2017-02-02	Boehringer Ingelheim International Gmbh	Pharmaceutical combination
CN101684121B (zh) *	2008-09-22	2013-04-03	重庆医药工业研究院有限责任公司	培美曲塞二酸的新晶型及其制备方法
EP2504341A1 (fr)	2009-11-24	2012-10-03	Azad Pharmaceutical Ingredients AG	Nouvelle forme cristalline du pemetrexed disodique
EP3210629A1 (fr)	2012-05-30	2017-08-30	Fresenius Kabi Oncology Ltd	Composition pharmaceutique de pemetrexed
ITRM20120398A1 (it)	2012-08-08	2014-02-09	Berlin Chemie Ag	Procedimento di sintesi pemetrexed e suo sale di lisina.
US20160051679A1 (en)	2013-04-12	2016-02-25	Actavis Group Ptc Ehf.	Pemetrexed Formulation
WO2014185797A1 (fr)	2013-05-17	2014-11-20	Instytut Farmaceutyczny	Procédé pour la préparation de pemetrexed disodique amorphe de haute pureté et formes cristallines de l'acide n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]pyrimidin-5-yl)éthyl]benzoyl]-l-glutamique
US20160145260A1 (en)	2013-06-14	2016-05-26	Synthon B.V.	Stable pemetrexed arginine salt and compositions comprising it
EP3021849B1 (fr) *	2013-07-16	2019-10-09	Dr. Reddy's Laboratories Ltd.	Nouvelles formes cristallines de sels de trométhamine de pemetrexed
NZ630292A (en)	2013-11-25	2015-02-27	Shilpa Medicare Ltd	Process for crystalline pemetrexed dipotassium salt
PT3206666T (pt)	2014-10-16	2020-03-11	Synthon Bv	Composição farmacêutica líquida compreendendo pemetrexedo
CN104672241B (zh) *	2015-01-29	2018-04-24	王磊	吡咯并[2,3-d]嘧啶类化合物及其用途
FR3037956B1 (fr) *	2015-06-23	2017-08-04	Servier Lab	Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES3057783T3 (en)	2016-03-15	2026-03-04	Oryzon Genomics Sa	Combinations of lsd1 inhibitors for use in the treatment of neoplastic diseases
EP3675864A4 (fr) *	2017-08-31	2022-02-16	Duquesne University of The Holy Spirit	Inhibiteurs de shmt2 et de mthfd2 de première catégorie utilisés comme agents antitumoraux
CN110305137A (zh) *	2018-03-20	2019-10-08	鲁南制药集团股份有限公司	一种培美曲塞二钠中间体及其制备方法
CN110305134B (zh) *	2018-03-20	2022-02-22	鲁南制药集团股份有限公司	一种培美曲塞二钠中间体及其制备方法
CN110305136A (zh) *	2018-03-20	2019-10-08	鲁南制药集团股份有限公司	一种培美曲塞二钠中间体及其制备方法
CN110305135B (zh) *	2018-03-20	2022-02-22	鲁南制药集团股份有限公司	一种培美曲塞二钠中间体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4818819A (en) *	1986-10-20	1989-04-04	The Trustees Of Princeton University	Process for the preparation of fused pyridine compounds
NO169490C (no) *	1988-03-24	1992-07-01	Takeda Chemical Industries Ltd	Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater
DK172753B1 (da) *	1988-05-25	1999-06-28	Lilly Co Eli	N-(5,6,7,8-tetrahydropyrido[2,3--d]pyrimidin-6-yl-alkanoyl)-glutaminsyrederivater, deres anvendelse, farmaceutiske præparat
US4883799A (en) *	1988-06-29	1989-11-28	The Trustees Of Princeton University	N-(4-(1-hydroxy-3-(5,6,7,8-tetrahydropyrido(2,3,-d)-pyrimidin-6-yl)prop-2-yl)benzoyl)glutamic acid derivatives

1990
- 1990-12-04 IL IL9653190A patent/IL96531A/en active Protection Beyond IP Right Term
- 1990-12-05 AU AU67791/90A patent/AU640182B2/en not_active Expired
- 1990-12-07 NZ NZ236385A patent/NZ236385A/en unknown
- 1990-12-10 SG SG1996007025A patent/SG48098A1/en unknown
- 1990-12-10 DK DK90123671.1T patent/DK0432677T3/da active
- 1990-12-10 PT PT96140A patent/PT96140B/pt not_active IP Right Cessation
- 1990-12-10 AR AR90318580A patent/AR245129A1/es active
- 1990-12-10 AT AT90123671T patent/ATE135007T1/de active
- 1990-12-10 DE DE69025723T patent/DE69025723T2/de not_active Expired - Lifetime
- 1990-12-10 DE DE200512000012 patent/DE122005000012I2/de active Active
- 1990-12-10 IE IE444590A patent/IE904445A1/en not_active IP Right Cessation
- 1990-12-10 CA CA002031890A patent/CA2031890C/fr not_active Expired - Lifetime
- 1990-12-10 HU HU147/90A patent/HU218483B/hu unknown
- 1990-12-10 EP EP90123671A patent/EP0432677B1/fr not_active Expired - Lifetime
- 1990-12-10 ES ES90123671T patent/ES2084639T4/es not_active Expired - Lifetime
- 1990-12-11 JP JP2409992A patent/JP3016876B2/ja not_active Expired - Lifetime
- 1990-12-11 CN CN90110125A patent/CN1030608C/zh not_active Ceased
1991
- 1991-02-07 RU SU4894454/04A patent/RU2057131C9/ru active Protection Beyond IP Right Term
1996
- 1996-04-29 GR GR960401164T patent/GR3019784T3/el unknown
1997
- 1997-12-22 HK HK97102541A patent/HK1000920A1/en not_active IP Right Cessation
1998
- 1998-09-11 CY CY9802076A patent/CY2076B1/xx unknown
2005
- 2005-03-14 LU LU91147C patent/LU91147I2/fr unknown
- 2005-03-16 NL NL300181C patent/NL300181I2/nl unknown

Also Published As

Publication number	Publication date
AU6779190A (en)	1991-06-13
HUT58335A (en)	1992-02-28
NZ236385A (en)	1992-05-26
SG48098A1 (en)	1998-04-17
NL300181I1 (nl)	2005-05-02
IL96531A (en)	1995-08-31
DE122005000012I2 (de)	2006-02-09
HK1000920A1 (en)	1998-05-08
CA2031890C (fr)	2000-07-25
AU640182B2 (en)	1993-08-19
HU908147D0 (en)	1991-06-28
RU2057131C9 (ru)	2006-04-10
DE69025723D1 (de)	1996-04-11
CA2031890A1 (fr)	1991-06-12
ATE135007T1 (de)	1996-03-15
PT96140B (pt)	1997-06-30
IE904445A1 (en)	1991-06-19
DE69025723T2 (de)	1996-10-31
ES2084639T4 (es)	2013-06-11
EP0432677B1 (fr)	1996-03-06
NL300181I2 (nl)	2005-06-01
AR245129A1 (es)	1993-12-30
HU218483B (hu)	2000-09-28
DE122005000012I1 (de)	2005-06-23
CN1055182A (zh)	1991-10-09
IL96531A0 (en)	1991-09-16
JP3016876B2 (ja)	2000-03-06
DK0432677T3 (da)	1996-04-09
RU2057131C1 (ru)	1996-03-27
ES2084639T3 (es)	1996-05-16
CN1030608C (zh)	1996-01-03
JPH083166A (ja)	1996-01-09
PT96140A (pt)	1991-09-30
CY2076B1 (en)	1998-09-11
EP0432677A1 (fr)	1991-06-19
GR3019784T3 (en)	1996-07-31

Publication	Publication Date	Title
LU91147I2 (fr)	2005-05-17	Pemetrexed et ses sels pharmaceutiquement acceptables.
LU91452I2 (fr)	2008-08-04	"Mycafungine et ses sels pharmaceutiquement acceptables(MYCAMINEr)"
LU90829I2 (fr)	2001-11-12	Tepoxalin-zubrin et ses d-riv-s pharmaceutiquement acceptables
LU90484I2 (fr)	2000-02-21	Novorapid - insuline asparte et ses sels et derives pharmaceutiquement acceptables
LU90736I2 (fr)	2001-05-07	Agenerase-amprenavir et ses d-riv-s pharmaceutiquement acceptables
LU91076I2 (fr)	2004-07-05	Tulathromycin et ses sels pharmaceutiquement acceptables (draxxin).
LU91291I2 (fr)	2007-01-29	Deferasirox et ses sels pharmaceutiquement acceptables (EXJADEr)
LU88576I2 (fr)	1995-03-21	RISPERIDONE et ses sels pharmaceutiquement acceptables (Risperdal R)
LU91039I2 (fr)	2003-11-05	Proteq flu et ses dérivés pharmaceutiquement acceptables
NO2001002I1 (no)	2001-02-12	Lamivudin, eventuelt i form av et farmasøytisk godtgbart salt
LU90069I2 (fr)	1997-07-23	Lercanidipine et ses sels et dérivés pharmaceutiquement acceptables (Zanidip)
FI891242A7 (fi)	1989-09-18	Foerfarande foer strimloes applicering av tunna kontrollerade fluidbelaeggningar och foer detta foerfarande avsedd valsbelaeggningsanordning med springmunstycke.
FI950908A7 (fi)	1995-04-28	Antitussiivi
FI920631A0 (fi)	1992-02-14	Polymer med hoegt tg-vaerde och aoterdispergerbart pulver foer anvaendning i hydrauliskt portland- cementmurbruk och -betong.
LU91345I2 (fr)	2007-09-04	Rufinamide et ses sels pharmaceutiquement acceptables (inovelon)
DE68901250D1 (de)	1992-05-21	Golfball.
FI890968L (fi)	1990-01-23	Behaollarlock med loestagbar kolv och med saodant lock foersedd spridningsbehaollare.
TR24804A (tr)	1992-03-26	Darbe yutucu, takilabilir parca
LU88790I2 (fr)	1997-03-18	Moxidectin et ses dérivés pharmaceutiquement acceptables
DE68901611D1 (de)	1992-06-25	Golfball.
DE68907394D1 (de)	1993-08-05	Golfball.
FI891382A0 (fi)	1989-03-22	Ljusintensitetsstyrkoppling foer gloedlampor och kopplingsnaetdelar med en skydds- och begraensningskoppling foer erhaollande av en elektronisk saekring.
LU88574I2 (fr)	1995-03-01	CEFEPIME et ses sels pharmaceutiquement acceptables (Maxipime R)
FI883349L (fi)	1990-01-15	Plastform med metallyta och foerfarande foer framstaellning av denna.
FI892578L (fi)	1989-12-22	Galvaniseringsbad foer utfaellning av funktionellt blankt och slaett krom med hoeg verkningsgrad.